AUROPHARMA

Aurobindo Pharma Limited

Pharmaceuticals

Share price

₹1,693

Market cap

₹97,239 Cr

1Y return

▲ 54%

A major manufacturer of active pharmaceutical ingredients and generic pharmaceuticals, Aurobindo Pharma produces a diverse range of pharmaceutical products serving domestic and international markets. The company operates across multiple therapeutic segments and maintains manufacturing facilities that comply with global quality standards. Its vertically integrated operations, coupled with significant research and development capabilities, distinguish it as a key player in India's pharmaceutical sector.

Investors holding Aurobindo Pharma Limited

SBI Mutual Fund

Mutual Fund

3.57%

HDFC Mutual Fund

Mutual Fund

3.22%

Institution

2.32%

Quant Mutual Fund

Mutual Fund

0.02%

ICICI Prudential Mutual Fund

Mutual Fund

0.02%

Recent moves 6

HDFC Mutual FundDecreased

HDFC Mutual Fund fully exited Aurobindo Pharma, selling its remaining 1.82 crore shares worth ₹2,790 Cr. This reduced its stake from 3.20% to 0.00%.

Quant Mutual FundDecreased

Quant Mutual Fund reduced its stake in Aurobindo Pharma by selling 371,210 shares, decreasing its holding from 28,869,269 shares to 28,498,059 shares. The shares were valued at approximately ₹56.96 crore based on the share price of ₹1532.00. Quant Mutual Fund participated in Aurobindo Pharma's buyback, tendering shares at ₹1,475 per share.

Bandhan Mutual FundExited

Bandhan Mutual Fund has dropped off Aurobindo Pharma Limited's disclosed shareholder list, meaning either a complete exit or a reduction of its stake to below the 1 percent reporting threshold.

ICICI Prudential Mutual FundExited

ICICI Prudential Mutual Fund, which previously held 2.09 percent of Aurobindo Pharma Limited, no longer appears on the company's disclosed shareholder list, indicating either a complete exit or a reduction of its stake to below 1 percent.

SBI Mutual FundIncreased

SBI Mutual Fund increased its stake in Aurobindo Pharma from 1.87% to 3.57%, acquiring 18,696,370 shares. The current share price of Aurobindo Pharma is ₹1532.00, making the value of the acquired shares approximately ₹2,863.38 crore.

LIC increased its holding in Aurobindo Pharma by acquiring 7,667 additional shares, bringing its total to 3,538,466 shares. This stake, while still below 1%, is valued at approximately ₹1.17 crore based on Aurobindo Pharma's share price of ₹1532.00.

Track the whales in Aurobindo Pharma Limited

Get alerted the moment a top investor buys or sells.